Membrane effects of beta-adrenergic blocking agents: investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D000526:Alprenolol / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000814:Aniline Compounds; D001665:Binding Sites; D001798:Blood Proteins / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000187:drug effects*; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D008566:Membranes / Q000187:drug effects; D009281:Naphthalenes; D010869:Pindolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013015:Sotalol / Q000494:pharmacology; D013050:Spectrometry, Fluorescence; D013451:Sulfonic Acids
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000814:Aniline Compounds; D001798:Blood Proteins; D009281:Naphthalenes; D013451:Sulfonic Acids; D000526:Alprenolol; D011433:Propranolol; D013015:Sotalol; D010869:Pindolol